Dual-Policy Drive: Organoid Drug Sensitivity Testing Achieves Key Breakthroughs with National Standards and Price Approval

2026-07-02

Dual-Policy Drive: Organoid Drug Sensitivity Testing Achieves Key Breakthroughs with National Standards and Price Approval

Details>

The FDA has launched Operation TrialBlazer, a comprehensive, end-to-end reform initiative, with NAMs—organ-on-a-chip technology—emerging as a core compliance‑driven evaluation tool for new drugs.

2026-06-26

The FDA has launched Operation TrialBlazer, a comprehensive, end-to-end reform initiative, with NAMs—organ-on-a-chip technology—emerging as a core compliance‑driven evaluation tool for new drugs.

Details>

The NIH has established a new dedicated office, marking a comprehensive shift in scientific research toward an ex vivo biomimetic evaluation framework.

2026-06-20

The NIH has established a new dedicated office, marking a comprehensive shift in scientific research toward an ex vivo biomimetic evaluation framework.

Details>

A New Global Regulatory Trend: Europe and the U.S. Ease Restrictions on Animal Testing, While Organ-on-a-Chip Technology Reaches a Major Industry Inflection Point

2026-06-02

A New Global Regulatory Trend: Europe and the U.S. Ease Restrictions on Animal Testing, While Organ-on-a-Chip Technology Reaches a Major Industry Inflection Point

Details>

China’s national medical insurance authority is proactively positioning itself in the organ-on-a-chip field, with Aiweide Bio playing a key role in driving industry development.

2026-05-28

China’s national medical insurance authority is proactively positioning itself in the organ-on-a-chip field, with Aiweide Bio playing a key role in driving industry development.

Details>

Breaking News: The Innovative Methods Evaluation Center of the National Institute for Food and Drug Control Has Officially Been Established! Organ-on-a-Chip Technology and Artificial Intelligence Provide Strategic Technological Support for China’s Transformation into a Leading Pharmaceutical Power.

2026-05-11

Breaking News: The Innovative Methods Evaluation Center of the National Institute for Food and Drug Control Has Officially Been Established! Organ-on-a-Chip Technology and Artificial Intelligence Provide Strategic Technological Support for China’s Transformation into a Leading Pharmaceutical Power.

Details>

FDA Announces: The First Year of Alternatives to Animal Testing a Success, Ushering in a Paradigm Shift in Global Drug Research

2026-04-22

FDA Announces: The First Year of Alternatives to Animal Testing a Success, Ushering in a Paradigm Shift in Global Drug Research

Details>

2026 Drug Administration Research Association Project Kick-off Meeting: Research on the Standardized Construction and Evaluation System for Organoid/Organ-on-a-Chip Models and Regulatory Science

2026-04-22

2026 Drug Administration Research Association Project Kick-off Meeting: Research on the Standardized Construction and Evaluation System for Organoid/Organ-on-a-Chip Models and Regulatory Science

Details>

The first batch of NIH grants has been awarded, with $9 million supporting research on organ-on-a-chip models of bone cancer and its metastatic mechanisms.

2026-04-16

The first batch of NIH grants has been awarded, with $9 million supporting research on organ-on-a-chip models of bone cancer and its metastatic mechanisms.

Details>

Accelerating the破解 of “immunosenescence”: Organ-on-a-chip scientific experiments aboard the space station

2026-04-13

Accelerating the破解 of “immunosenescence”: Organ-on-a-chip scientific experiments aboard the space station

Details>

From Guidelines to Budget: The FDA Is Systematically Advancing Organ-on-a-Chip and Other NAMs | A Comprehensive Review of FDA Regulatory Actions for 2025–2026

2026-04-10

From Guidelines to Budget: The FDA Is Systematically Advancing Organ-on-a-Chip and Other NAMs | A Comprehensive Review of FDA Regulatory Actions for 2025–2026

Details>

Major Policy Announcement: Organoids and Organ-on-a-Chip Technologies Have Been Incorporated into Beijing’s Innovation Development Strategy by Ten Government Departments.

2026-04-08

Major Policy Announcement: Organoids and Organ-on-a-Chip Technologies Have Been Incorporated into Beijing’s Innovation Development Strategy by Ten Government Departments.

Details>

< 12345 >

We use optional cookies to improve your experience on our website, including through social media connections, and to personalize ads based on your online activity. If you refuse optional cookies, we will only use cookies that are necessary to provide you with the services.Privacy Statement